Published in J Gastroenterol on June 09, 2010
Effect of Nordic Walking training on iron metabolism in elderly women. Clin Interv Aging (2015) 1.24
Hepcidin in the diagnosis of iron disorders. Blood (2016) 0.93
Do high blood hepcidin concentrations contribute to low ferritin levels in young tennis players at the end of tournament season? J Sports Sci Med (2013) 0.82
Hepcidin expression in iron overload diseases is variably modulated by circulating factors. PLoS One (2012) 0.77
Inclusion bodies of aggregated hemosiderins in liver macrophages. Med Mol Morphol (2017) 0.75
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet (1996) 26.06
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science (2004) 19.19
A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem (2000) 8.52
Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem (2000) 8.39
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood (2002) 7.58
Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet (2003) 5.82
Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A (2001) 5.77
Immunoassay for human serum hepcidin. Blood (2008) 5.32
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett (2000) 5.22
Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet (2003) 4.49
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet (2002) 4.19
Global prevalence of putative haemochromatosis mutations. J Med Genet (1997) 4.03
Hepcidin is decreased in TFR2 hemochromatosis. Blood (2004) 3.46
Suppression of hepcidin during anemia requires erythropoietic activity. Blood (2006) 3.32
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet (2000) 3.08
Hepcidin in iron overload disorders. Blood (2005) 2.88
Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest (2001) 2.49
Iron and chronic viral hepatitis. Hepatology (1997) 2.18
Two novel mutations, L490R and V561X, of the transferrin receptor 2 gene in Japanese patients with hemochromatosis. Haematologica (2005) 2.12
The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci U S A (2005) 2.10
Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood (2005) 2.02
Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci U S A (1995) 2.01
In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood (2005) 1.96
The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem (2002) 1.89
Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion. J Hepatol (2008) 1.85
A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet (2001) 1.83
Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J (2007) 1.69
Iron overload in the Asian community. Blood (2009) 1.59
Diferric transferrin regulates transferrin receptor 2 protein stability. Blood (2004) 1.56
Reduced serum hepcidin levels in patients with chronic hepatitis C. J Hepatol (2009) 1.48
Regulation of transferrin receptor 2 protein levels by transferrin. Blood (2004) 1.47
Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry. Blood (2007) 1.41
Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology (1987) 1.37
The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease? Clin J Am Soc Nephrol (2006) 1.29
Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans. Blood Cells Mol Dis (2003) 1.24
Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels. Br J Haematol (2008) 1.19
Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up. Rapid Commun Mass Spectrom (2007) 1.14
Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C. J Clin Gastroenterol (2005) 1.10
Genetic and clinical heterogeneity of ferroportin disease. Br J Haematol (2005) 1.07
Autosomal dominant reticuloendothelial iron overload (HFE type 4) due to a new missense mutation in the FERROPORTIN 1 gene (SLC11A3) in a large French-Canadian family. Haematologica (2003) 1.01
Novel mutation in ferroportin 1 gene is associated with autosomal dominant iron overload. J Hepatol (2003) 1.00
Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation. Haematologica (2008) 0.98
Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease. Hepatology (2005) 0.95
Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance. World J Gastroenterol (2007) 0.89
Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation. Gut (2004) 0.84
A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron. Intern Med (2005) 0.84
Three patients with middle-age-onset hemochromatosis caused by novel mutations in the hemojuvelin gene. J Hepatol (2005) 0.83
AVAQ 594-597 deletion of the TfR2 gene in a Japanese family with hemochromatosis. Hepatol Res (2003) 0.77
Hepcidin, an antimicrobial peptide is downregulated in ceruloplasmin-deficient mice. Peptides (2008) 0.77
Serum prohepcidin levels correlate with hepatic iron stores in chronic hepatitis C patients. Hepatogastroenterology (2009) 0.75
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol (2011) 4.26
Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation (2005) 3.10
Effect of vitamin K2 on the recurrence of hepatocellular carcinoma. Hepatology (2011) 3.00
Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis. Nat Chem Biol (2006) 2.75
Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol (2004) 2.69
Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol (2005) 2.46
Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2010) 2.33
Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: the Low Density Lipoprotein-Apheresis Coronary Morphology and Reserve Trial (LACMART). J Am Coll Cardiol (2002) 2.26
Two novel mutations, L490R and V561X, of the transferrin receptor 2 gene in Japanese patients with hemochromatosis. Haematologica (2005) 2.12
Inhibition of mTORC2 but not mTORC1 up-regulates E-cadherin expression and inhibits cell motility by blocking HIF-2α expression in human renal cell carcinoma. J Urol (2012) 2.08
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy. Cancer (2004) 2.03
Long QT syndrome with compound mutations is associated with a more severe phenotype: a Japanese multicenter study. Heart Rhythm (2010) 2.00
Can magnifying endoscopy with narrow band imaging be useful for low grade adenomas in preoperative biopsy specimens? Gastric Cancer (2012) 1.95
Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion. J Hepatol (2008) 1.85
A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan. J Gastroenterol (2004) 1.83
Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury. J Am Soc Nephrol (2003) 1.80
Mutations in a thiamine-transporter gene and Wernicke's-like encephalopathy. N Engl J Med (2009) 1.79
Gene and protein expression analysis of mesenchymal stem cells derived from rat adipose tissue and bone marrow. Circ J (2011) 1.70
Failure to prevent progressive dilation of ascending aorta by aortic valve replacement in patients with bicuspid aortic valve: comparison with tricuspid aortic valve. Circulation (2003) 1.69
Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C. Am J Gastroenterol (2002) 1.63
Efficacy of peginterferon-alpha-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis C. Liver Int (2009) 1.62
Images in cardiovascular medicine. "Arteries within the artery" after Kawasaki disease: a lotus root appearance by intravascular ultrasound. Circulation (2002) 1.61
Trafficking-competent KCNQ1 variably influences the function of HERG long QT alleles. Heart Rhythm (2010) 1.61
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood (2004) 1.59
Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains. J Gastroenterol Hepatol (2010) 1.56
Impact of severe earthquake on the occurrence of acute coronary syndrome and stroke in a rural area of Japan. Circ J (2009) 1.55
Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome. Diabetes Res Clin Pract (2007) 1.52
Aceruloplasminemia, an inherited disorder of iron metabolism. Biometals (2003) 1.52
Exome sequencing in suspected monogenic dyslipidemias. Circ Cardiovasc Genet (2015) 1.51
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica (2009) 1.51
Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors. Hepatology (2010) 1.50
An enhanced device for transluminal retrieval of vascular stents without surgical procedures: experimental studies. J Interv Cardiol (2010) 1.50
Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody. Circ Cardiovasc Genet (2015) 1.50
Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J (2005) 1.49
Impact of visceral adipose tissue and subcutaneous adipose tissue on insulin resistance in middle-aged Japanese. J Atheroscler Thromb (2012) 1.47
Impact of Elevated D-Dimer on Diagnosis of Acute Aortic Dissection With Isolated Neurological Symptoms in Ischemic Stroke. Circ J (2015) 1.46
Current state of Wilson disease patients in central Japan. Intern Med (2010) 1.45
Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. J Am Soc Nephrol (2004) 1.44
A novel mutation in the transmembrane nonpore region of the KCNH2 gene causes severe clinical manifestations of long QT syndrome. Heart Rhythm (2012) 1.44
Ablation of the Ccr2 gene exacerbates polyarthritis in interleukin-1 receptor antagonist-deficient mice. Arthritis Rheum (2011) 1.42
Weekend onset of acute myocardial infarction does not have a negative impact on outcome in Japan. Circ J (2007) 1.42
Primary Sjögren's syndrome with chronic tubulointerstitial nephritis and lymphadenopathy mimicking IgG4-related disease. Mod Rheumatol (2013) 1.42
Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells. Biochem Biophys Res Commun (2008) 1.42
Lipoprotein(a) in Familial Hypercholesterolemia With Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gain-of-Function Mutations. Circ J (2015) 1.41
Higher than expected progranulin mutation rate in a case series of Italian FTLD patients. Alzheimer Dis Assoc Disord (2009) 1.40
Apparent genotype-phenotype correlation in childhood, adolescent, and adult Chediak-Higashi syndrome. Am J Med Genet (2002) 1.39
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project. Blood (2010) 1.37
Two genetic variants of CD38 in subjects with autism spectrum disorder and controls. Neurosci Res (2010) 1.35
Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol (2005) 1.31
Comparison of waist circumference with body mass index for predicting abdominal adipose tissue. Diabetes Res Clin Pract (2008) 1.28
Expanding the clinical phenotype of SNCA duplication carriers. Mov Disord (2009) 1.25
Huge saccular aneurysm in a coronary-pulmonary fistula fed by the left and right coronary arteries. Circ J (2002) 1.24
Impacts of visceral adipose tissue and subcutaneous adipose tissue on metabolic risk factors in middle-aged Japanese. Obesity (Silver Spring) (2009) 1.23
Patternable solution-crystallized organic transistors with high charge carrier mobility. Adv Mater (2011) 1.21
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. Blood Cells Mol Dis (2007) 1.20
Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries. Mov Disord (2006) 1.20
Bilateral epididymal sarcoidosis presenting without radiographic evidence of intrathoracic lesion: Review of sarcoidosis involving the male reproductive tract. Int J Urol (2004) 1.19
Risk of colorectal neoplasm in patients with acromegaly and its relationship with serum growth hormone levels. Am J Gastroenterol (2005) 1.18
Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus. J Gastroenterol (2003) 1.16
Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia. Am J Physiol Heart Circ Physiol (2010) 1.15
Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production. Rheumatol Int (2009) 1.13
Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan. Hepatol Res (2010) 1.13
Mechanisms of copper incorporation into human ceruloplasmin. J Biol Chem (2002) 1.13
Chronological development of elevated aminotransferases in a nonalcoholic population. Hepatology (2005) 1.12
Linear- and angular-shaped naphthodithiophenes: selective synthesis, properties, and application to organic field-effect transistors. J Am Chem Soc (2011) 1.11
Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). Am J Cardiol (2005) 1.10
Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 1.10
Acute urinary retention as an unusual manifestation of aseptic meningitis. Intern Med (2002) 1.09
Cerebral sparganosis: the wandering lesion. Neurology (2010) 1.08
Natural history of juvenile haemochromatosis. Br J Haematol (2002) 1.07
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis. Haematologica (2010) 1.07
Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease. Circ Res (2017) 1.06
Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma. BMC Cancer (2008) 1.06
Lymphokine-activated killer T-cell-originated protein kinase phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells. Clin Cancer Res (2006) 1.05
Systemic capillary leak syndrome associated with compartment syndrome. Intern Med (2007) 1.04
Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease. Haematologica (2007) 1.04
The neurological presentation of ceruloplasmin gene mutations. Eur Neurol (2008) 1.02